Efficacy and safety of darolutamide (DARO) in combination with androgen-deprivation therapy (ADT) and docetaxel (DOC) by disease volume and disease risk in the phase 3 ARASENS study.

An enhanced patient navigation-based intervention improved delivery of timely postoperative radiation for head and neck cancer vs. usual care. The approach also narrowed racial disparities in care ...